Skip to main content

Market Overview

UBS Initiates Genesis Healthcare With Neutral


UBS initiated coverage on Genesis Healthcare Inc (NYSE: GEN) with a Neutral rating.

The target price for Genesis Healthcare is set to $7.

Genesis Healthcare shares have gained 1.24 percent over the past 52 weeks, while the S&P 500 index has surged 4.27 percent in the same period.

Genesis Healthcare shares fell 2.97 percent to close at $6.53 yesterday.

Latest Ratings for GEN

Jan 2021Credit SuisseDowngradesNeutralUnderperform
Nov 2020Credit SuisseMaintainsNeutral
Nov 2018Stifel NicolausUpgradesHoldBuy

View More Analyst Ratings for GEN
View the Latest Analyst Ratings


Related Articles (GEN)

View Comments and Join the Discussion!

Posted-In: UBSInitiation Analyst Ratings

Latest Ratings

APENLake StreetInitiates Coverage On12.0
PATHMacquarieInitiates Coverage On69.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at